TY - JOUR
T1 - Vitrectomy treatment of vitreous opacities
AU - Peyman, G. A.
AU - Huamonte, F. U.
AU - Goldberg, M. F.
PY - 1976/1/1
Y1 - 1976/1/1
N2 - Twenty one patients suffering from vitreous opacities caused by central and branch vein occlusion, sickle cell retinopathy, retinal vasculitis, endophthalmitis, hypertensive retinopathy, and uveitis underwent pars plana vitrectomy with the vitrophage. Intraoperative complications included retinal tears in two eyes with sickle cell retinopathy and tractional retinal detachment. Both were successfully treated. Postoperative complications were recurrent vitreous hemorrhage, hemolytic glaucoma, and corneal blood staining in a patient suffering from sickle cell retinopathy. Long standing corneal edema was observed in patients suffering from endophthalmitis. Visual acuity improved in 95% of our patients and was worse in 5% of the patients.
AB - Twenty one patients suffering from vitreous opacities caused by central and branch vein occlusion, sickle cell retinopathy, retinal vasculitis, endophthalmitis, hypertensive retinopathy, and uveitis underwent pars plana vitrectomy with the vitrophage. Intraoperative complications included retinal tears in two eyes with sickle cell retinopathy and tractional retinal detachment. Both were successfully treated. Postoperative complications were recurrent vitreous hemorrhage, hemolytic glaucoma, and corneal blood staining in a patient suffering from sickle cell retinopathy. Long standing corneal edema was observed in patients suffering from endophthalmitis. Visual acuity improved in 95% of our patients and was worse in 5% of the patients.
UR - http://www.scopus.com/inward/record.url?scp=0016959332&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0016959332&partnerID=8YFLogxK
M3 - Article
C2 - 960361
AN - SCOPUS:0016959332
SN - 0002-7154
VL - 81
SP - OP-394-398
JO - Transactions of the American Academy of Ophthalmology and Otolaryngology
JF - Transactions of the American Academy of Ophthalmology and Otolaryngology
IS - 3 I
ER -